LivaNova (LIVN) Change in Acquisitions & Divestments (2015 - 2025)

LivaNova (LIVN) posted Change in Acquisitions & Divestments of $6.5 million for Q2 2025, down 7.47% sequentially from $7.0 million in Q3 2016.

LivaNova (LIVN) Change in Acquisitions & Divestments (2015 - 2025) Analysis & Trends

LivaNova has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $6.5 million in Q2 2025.

Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $6.5 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $6.5 million, changed N/A from the prior year.
Change in Acquisitions & Divestments eased to $6.5 million in Q2 2025 per LIVN's latest filing, from $7.0 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $6.5 million in Q2 2025 and troughed at $6.5 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.91 Bn	193.31 Bn	7.27 Bn
2	Stryker	127.59 Bn	124.11 Bn	4.50 Bn
3	Medtronic	118.77 Bn	109.55 Bn	6.41 Bn
4	Boston Scientific	73.24 Bn	72.70 Bn	3.85 Bn
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn
6	Dexcom	34.38 Bn	32.44 Bn	830.00 Mn
7	GE HealthCare Technologies	33.96 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.08 Bn	22.60 Bn	684.20 Mn
10	LivaNova	4.29 Bn	3.77 Bn	273.67 Mn

Download Data